In order to assess the presence of anxiolytic properties in cannabidiol (CBD) the drug was tested in an elevated plus-maze model of anxiety, in rats. Doses of 2.5, 5.0 and 10.0 mg/kg significantly increased the entry ratio (open/total number of entries), an anxiolytic-like effect. CBD at a dose of 20.0 mg/kg was no longer effective. None of the doses of CBD used changed total number of entries, a measure of total exploratory activity. Diazepam (2.0 mg/kg) also caused an anxiolytic-like effect in this model. These results indicate that CBD causes a selective anxiolytic effect in the elevated plusmaze, within a limited range of doses.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price includes VAT (USA)
Tax calculation will be finalised during checkout.
Cunha JM, Carlini EA, Pereira AE, Ramos OL, Pimentel C, Gagliardi R, Sannito WL, Lander N, Mechoulam R (1980) Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology 21:175–185
Dewey WL (1986) Cannabidiol pharmacology. Pharmacol Rev 38:151–178
Grlie L (1976) A comparative study on some chemical and biological characteristics of various samples of cannabis resin. Bull Narc 14:37–46
Pellow S, File SE (1986) Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze. A novel test of anxiety in the rat. Pharmacol Biochem Behav 24:525–529
Pellow S, Chopin P, File SE, Briley M (1985) Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149–167
Silveira Filho NG, Tufik S (1981) Comparative effects between cannabidiol and diazepam on neophobia, food intake and conflict behavior. Res Commun Psychol Psychiatr Behav 6:25–66
Sofia RD, Kubena RK, Barry H (1971) Comparison of four vehicles for intraperitoneal administration of 1-tetrahydrocannabinol. J Pharm Pharmacol 23:889–891
Zuardi AW, Karniol IG (1983) Changes in the conditioned emotional response of rats induced by 9-THC, CBD and mixture of the two cannabinoids. Arq Biol Tecnol 26:391–397
Zuardi AW, Shirakawa I, Finkelfarb E, Karniol IG (1982) Action of cannabidiol on the anxiety and other effects produced by 9-THC in normal subjects. Psychopharmacology 76:245–250
About this article
Cite this article
Guimarães, F.S., Chiaretti, T.M., Graeff, F.G. et al. Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmacology 100, 558–559 (1990). https://doi.org/10.1007/BF02244012
- Elevated plus-maze